ClinicalTrials.govpublic full text
Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.
heart failure, safety, efficacy, levosimendan, dobutamine, intravenous, invasive hemodynamics, decompensated heart failure, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845788
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.